Selectivity of BMS-180448 on myocardial versus brain blood flow in dogs and ferrets

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 1, 1997, Pages 61-68

  Weselcouch, Edward O ^a,b   Gomoll, Allen W ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b Focal Inc   (United States)

Author keywords

ATP sensitive K+ channels; Brain blood flow; Dog; Ferret; Hemodynamics; Potassium channel activator; Regional myocardial blood flow; Tissue blood flow

Indexed keywords

CROMAKALIM; N (4 CHLOROPHENYL) N' CYANO N'' (6 CYANO 3,4 DIHYDRO 3 HYDROXY 2,2 DIMETHYL 2H 1 BENZOPYRAN 4 YL)GUANIDINE; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; DOSE RESPONSE; DRUG SELECTIVITY; FERRET; HEART PROTECTION; HEMODYNAMICS; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; VASODILATATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; BENZOPYRANS; CEREBROVASCULAR CIRCULATION; CORONARY CIRCULATION; CROMAKALIM; DOGS; ELECTROPHYSIOLOGY; FERRETS; GUANIDINES; HEMODYNAMIC PROCESSES; MALE; POTASSIUM CHANNELS; PYRROLES; VASODILATOR AGENTS;

EID: 0030712296     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199707000-00009     Document Type: Article

References (29)

1. Grover GJ, Sleph PG, Dzwonczyk S. Pharmacologic profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs. J Cardiovasc Pharmacol 1990;16: 853-64.
2. Grover GJ, Dzwonczyk S, Parham CS, Sleph PG. The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs. Cardiovasc Drugs Ther 1990;4:465-74.
3. Grover GJ, Dzwonczyk S, Sleph PG. Reduction of ischemic damage in isolated rat hearts by the potassium channel opener, RP 52891. Eur J Pharmacol 1990;191:11-8.
4. Ohta H, Jinno Y, Harada K, Ogawa N, Fukushima H, Nishikori K. Cardioprotective effects of KRN2391 and nicorandil on ischemic dysfunction in perfused rat heart. Eur J Pharmacol 1991; 204: 171-7.
5. Sargent CA, Sleph PG, Dzwonczyk S, Normandin D, Antonaccio MJ, Grover GJ. Cardioprotective effects of the cyanoguanidine potassium channel opener P-1075. J Cardiovasc Pharmacol 1993; 22:564-70.
6. Toombs CF, Norman NR, Shebuski RJ. Reduction of infarct size with U-89232: a non-vasoactive analog of the potassium channel opener cromakalim [Abstract]. Circulation 1992;86:1-556.
7. + channel opener aprikalim (RP 52891) reduced experimental infarct size in dogs in the absence of hemodynamic changes. J Pharmacol Exp Ther 1991;259:961-7.
8. Auchampach JA, Gross GJ. Reduction in myocardial infarct size by the new potassium channel opener bimakalim. J Cardiovasc Pharmacol 1994;23:554-61.
9. Endo T, Nejima J, Kiuchi K, et al. Reduction of size of myocardial infarction with nicorandil, a new antianginal drug, after coronary artery occlusion in dogs. J Cardiovasc Pharmacol 1988;12: 587-92.
10. Sakamoto S, Liang C, Stone C, Hood W. Effects of pinacidil on myocardial blood flow and infarct size after acute left anterior descending coronary artery occlusion and reperfusion in awake dogs with and without a coexisting left circumflex coronary artery stenosis. J Cardiovasc Pharmacol 1989;14:747-55.
11. Atwal KS, Grover GJ, Ahmed SZ, et al. Cardioselective antiischemic ATP-sensitive potassium channel openers. J Med Chem 1993;36:3971-4.
12. Atwal KS, Grover GJ, Ferrara FN, et al. Cardioselective antiischemic ATP-sensitive potassium channel openers. 2. Structure-activity studies on benzopyranyl-cyanoguanidines: modification of the benzopyran ring. J Med Chem 1995;38:1967-73.
13. Grover GJ. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia. J Cardiovasc Pharmacol 1994;24(suppl 4):S18-27.
14. Grover GJ, McCullough JR, D'Alonzo AJ, Sargent CA, Atwal KS. Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448. J Cardiovasc Pharmacol 1995;25:40-50.
15. Zhang H, Stockbridge N, Weir B, Vollrath B, Cook D. Vasodilation of canine cerebral arteries by nicorandil, pinacidil and lemakalim. Gen Pharmacol 1992;23:197-201.
16. McCarron JG, Quayle JM, Halpern W, Nelson MT. Cromakalim and pinacidil dilate small mesenteric arteries but not small cerebral arteries. Am J Physiol 1991;261:H287-91.
17. Heymann MA, Payne BD, Hoffman JIE, Rudolph AM. Blood flow measurements with radionuclide-labeled particles. Prog Cardiovasc Dis 1977;20:55-79.
18. Flaim SF, Nellis SH, Toggart EJ, Drexler H, Kanda K, Newman ED. Multiple simultaneous determinations of hemodynamics and flow distribution in conscious rat. J Pharmacol Methods 1984;11: 1-39.
19. Weselcouch EO, Baird AJ. Effect of cromakalim on skeletal muscle function and blood flow in the ferret ischemic hindlimb. Pharmacology 1994;49:75-85.
20. Grover GJ, D'Alonzo AJ, Hess T, Sleph PG, Darbenzio RB. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening. Cardiovasc Res 1995;30:731-8.
21. Giuducelli J-F, la Rochelle CD, Berdeaux A. Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs. J Pharmacol Exp Ther 1990;255:836-42.
22. Hof RP, Quast U, Cook NS, Blarer S. Mechanism of action and systemic and regional hemodynamics of the potassium channel activator BRL 34915 and its enantiomers. Circulation 1988;62: 679-86.
23. Bache RJ, Dai X-Z, Baran KW. Effect of pinacidil on myocardial blood flow in the presence of a coronary artery stenosis. J Cardiovasc Pharmacol 1990;15:619-25.
24. Hof RP. Effects of isradipine and other calcium antagonists on arteriovenous-shunt flow in anesthetized rabbits and cats. Am J Med 1989;86(suppl 4A):40-9.
25. Shoji T, Aki Y, Fukui K, Tamaki T, Iwao H, Abe Y. Effects of cromakalim, a potassium channel opener on regional blood flow in conscious spontaneously hypertensive rats. Eur J Pharmacol 1990;186:119-23.
26. Buckingham RE, Clapman JC, Hamilton TC, Longman SD, Norton J, Poyser RH. BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other hemodynamic parameters with those of nifedipine in animal models. J Cardiovasc Pharmacol 1986;8:798-804.
27. Traystman RJ. Microcirculation of the brain. In: Mortillaro NA, ed. The physiology and pharmacology of the microcirculation. New York: Academic Press. 1983:237-97.
28. + channel openers. Br J Pharmacol 1992;105:51-8.
29. Andersson K-E. Clinical pharmacology of potassium channel openers. Pharmacol Toxicol 1992;70:244-54.